Natural killer cells during primary varicella zoster virus infection - 07/08/11
Doi : 10.1016/j.jinf.2010.05.004
Gathsaurie Neelika Malavige
MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK
Department of Microbiology, Faculty of Medical Sciences, University of Sri Jayawardanapura, Sri Lanka
Louise Jones
MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK
S.D. Kamaladasa
Department of Medicine, Faculty of Medical Sciences, University of Sri Jayawardanapura, Sri Lanka
Suranjith L. Seneviratne
Department of Clinical Immunology, Imperial College AHSC (St Mary’sHospital), London, UK
Antony P. Black
MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK
Graham S. Ogg ⁎ 
MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, Oxford, UK
Department of Dermatology, Churchill Hospital, Oxford, OX3 7LJ, UK
Corresponding author. Cutaneous Immunology Group, Weatherall Institute of Molecular Medicine, Oxford, OX3 9DS, UK. Tel.: +44(0) 1865 222334; fax: +44(0) 1865 222502.
Le texte complet de cet article est disponible en PDF.
© 2010
The British Infection Society. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 61 - N° 2
P. 190-192 - août 2010 Retour au numéro
Article précédent
- Severe acute renal failure associated with rhabdomyolysis during treatment with raltegravir. A call for caution
- Mar Masiá, Ricardo Enríquez, Ana Sirvent, Félix Gutiérrez
- Clindamycin-resistant Staphylococcus aureus in foot ulcers of patients with diabetes
- M.V. Regeer, A.C. van Bon, L. Spanjaard, T.E. Busch-Westbroek, C.H.M. van Schie, S.E. Geerlings, J.H. DeVries
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?